You are here

AstraZeneca

Can a little known drug in AstraZeneca's pipeline make a comeback as a PARP add-on? Yale scientists explain how

Endpoints

Thu, 05/16/19 - 11:51 am

PARP inhibitors

3 Top Diabetes Stocks to Watch in May

Motley Fool

Wed, 05/15/19 - 10:29 am

Alzheimer’s R&D projects sidelined as Biogen’s aducanumab shock shakes researchers to the core of their beliefs

Endpoints

Tue, 05/14/19 - 09:56 am

Alzheimer's disease

drug development

Forty Seven and AstraZenca Team up on NHL Triple-Combination Therapy

BioSpace

Fri, 05/10/19 - 05:58 pm

clinical trials

diffuse large B-cell lymphoma

Roxadustat safety analysis provokes more questions than answers

EP Vantage

Fri, 05/10/19 - 10:29 am

Researchers warn about gangrene cases in patients on SGLT2 diabetes drugs

Fierce Pharma

Thu, 05/9/19 - 11:04 pm

Boehringer Ingelheim

AstraZeneca's share dilution gamble on Daiichi drug pays off

Biopharma Dive

Thu, 05/9/19 - 10:49 am

trastuzumab deruxtecan

metastatic breast cancer

AZ and Daiichi to file new breast cancer drug after trial success

Pharmaforum

Wed, 05/8/19 - 10:05 am

trastuzumab deruxtecan

antibody-drug conjugate

Artificial Intelligence is Ramping up in Drug Development

BioSpace

Tue, 05/7/19 - 06:50 pm

drug development

artificial intelligence

Watch out AbbVie and J&J, AstraZeneca just took another big swing at one of your star cancer drug franchises

Endpoints

Tue, 05/7/19 - 10:15 am

clinical trials

chronic lymphocytic leukemia

FDA approves AstraZeneca's triple combination therapy for type 2 diabetes

Healio

Fri, 05/3/19 - 11:19 am

type 2 diabetes

AstraZeneca ups oncolytic virus activity with Transgene deal

Fierce Biotech

Thu, 05/2/19 - 11:22 am

oncolytic viruses

drug development

AZ researches kidney and lung drugs with BenevolentAI

Pharmaforum

Tue, 04/30/19 - 09:48 am

artificial intelligence

Lynparza on cusp of EU approval for advanced ovarian cancer

Pharmaforum

Mon, 04/29/19 - 10:28 am

Soriot sees progress in U.S.-China IP debate

BioCentury

Sat, 04/27/19 - 10:36 am

intellectual property

AstraZeneca dumps Amgen-partnered drug after midphase fail

Fierce Biotech

Fri, 04/26/19 - 11:46 am

Sjöogren’s syndrome

Newer drugs fuel AstraZeneca quarterly sales beat

Yahoo/Reuters

Fri, 04/26/19 - 10:34 am

Pfizer, AstraZeneca and J&J Take Issue With FDA’s List of Companies Withholding Drug Samples

RAPS.org

Fri, 04/12/19 - 11:46 pm

GSK, AstraZeneca explore continuous manufacturing in partnership with CPI

Biopharma Dive

Thu, 04/11/19 - 07:21 pm

continuous manufacturing

drug manufacturing

AZ and MSD’s Lynparza gets EU nod for hard-to-treat breast cancer

Pharmaforum

Wed, 04/10/19 - 09:46 am

BRCA-mutant breast cancer

Pages